American Board of Radiology, Certificate of Added Qualification, Neuroradiology
Certification
2014
Massachussetts General Hospital
Boston
- Neuroradiology Fellowship
2013
University of Rochester Medical Center
Rochester, NY
Residency - Diagnostic Radiology
2011
American Board of Radiology
Certification
2011
Columbia University
New York, NY
MS - Biomedical Engineering
2006
New York University School of Medicine
New York, NY
MD - Medicine
2005
Columbia University
New York, NY
BS - Biomedical Engineering
2001
Neoadjuvant Nivolumab Plus Chemotherapy Followed by Response-Stratified Chemoradiation Therapy in HPV-Negative Head and Neck Cancer: The DEPEND Phase 2 Nonrandomized Clinical Trial.
Neoadjuvant Nivolumab Plus Chemotherapy Followed by Response-Stratified Chemoradiation Therapy in HPV-Negative Head and Neck Cancer: The DEPEND Phase 2 Nonrandomized Clinical Trial. JAMA Oncol. 2025 May 01; 11(5):492-501.
PMID: 40048190
Preoperative and Postoperative CT Imaging Assessment of Obstructive Sleep Apnea.
Preoperative and Postoperative CT Imaging Assessment of Obstructive Sleep Apnea. J Comput Assist Tomogr. 2025 Mar 20.
PMID: 40165025
Assessment of commercially available artificial intelligence software for differentiating hemorrhage from contrast on head CT following thrombolysis for ischemic stroke.
Assessment of commercially available artificial intelligence software for differentiating hemorrhage from contrast on head CT following thrombolysis for ischemic stroke. Front Neurol. 2025; 16:1458142.
PMID: 40103936
The efficacy and safety of the addition of programmed cell death protein 1 inhibitor to preoperative chemotherapy in locoregionally advanced oropharyngeal carcinoma.
The efficacy and safety of the addition of programmed cell death protein 1 inhibitor to preoperative chemotherapy in locoregionally advanced oropharyngeal carcinoma. Transl Cancer Res. 2025 Feb 28; 14(2):1401-1414.
PMID: 40104753
A rare case report of colon metastasis from primary oropharyngeal squamous cell carcinoma treated with a combination of surgery, radiotherapy and immunotargeted therapy.
A rare case report of colon metastasis from primary oropharyngeal squamous cell carcinoma treated with a combination of surgery, radiotherapy and immunotargeted therapy. Transl Cancer Res. 2025 Feb 28; 14(2):1492-1499.
PMID: 40104747
A postmortem high-resolution MRI study of the development of cochlear nerve-related structures in the second and third trimesters of pregnancy.
A postmortem high-resolution MRI study of the development of cochlear nerve-related structures in the second and third trimesters of pregnancy. Quant Imaging Med Surg. 2024 Sep 01; 14(9):6325-6336.
PMID: 39281173
Imaging Features of Ectopic Nasopharyngeal Branchial Cleft Cyst With Temporal Bone Involvement.
Imaging Features of Ectopic Nasopharyngeal Branchial Cleft Cyst With Temporal Bone Involvement. Ear Nose Throat J. 2024 Aug 08; 1455613241271727.
PMID: 39115135
Emerging Head and Neck Tumor Targeting Contrast Agents for the Purpose of CT, MRI, and Multimodal Diagnostic Imaging: A Molecular Review.
Emerging Head and Neck Tumor Targeting Contrast Agents for the Purpose of CT, MRI, and Multimodal Diagnostic Imaging: A Molecular Review. Diagnostics (Basel). 2024 Aug 01; 14(15).
PMID: 39125542
Switching anti-EGFR antibody re-sensitizes head and neck cancer patient following acquired resistance to cetuximab.
Switching anti-EGFR antibody re-sensitizes head and neck cancer patient following acquired resistance to cetuximab. Cancer Gene Ther. 2024 Oct; 31(10):1477-1485.
PMID: 39085630
Neoadjuvant Nivolumab Plus Chemotherapy Followed By Response-Adaptive Therapy for HPV+ Oropharyngeal Cancer: OPTIMA II Phase 2 Open-Label Nonrandomized Controlled Trial.
Neoadjuvant Nivolumab Plus Chemotherapy Followed By Response-Adaptive Therapy for HPV+ Oropharyngeal Cancer: OPTIMA II Phase 2 Open-Label Nonrandomized Controlled Trial. JAMA Oncol. 2024 Jul 01; 10(7):923-931.
PMID: 38842838
ASNR Computer Sciences and Information Committee
ASNR Young Professionals Committee